BrikoNikolay I. Briko, D. Sci. (Medicine), Professor, Full Member of the Russian Academy of Sciences.

Head of the Department of epidemiology and evidence-based medicine, Director of the Institute of Public Health, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

SCOPUS AuthorIDORCIDMendeley

Research interests and main scientific achievements

He formulated the modern theoretic base of epidemiology and established its structure and subject. Fundamental epidemiologic research of Group A streptococcal infection, development of a surveillance system and new laboratory diagnosis and prevention methods of streptococcal infection were conducted under the scientific supervision of N.I. Briko.

Research of molecular epidemiology of Group A streptococcal infection was conducted for the first time in Russia. The epidemiological surveillance of Group A streptococcal infection, including microbiological and molecular biological monitoring of the pathogen, has been developed and implemented into a healthcare system. A significant contribution to improving the diagnosis and prevention of Group A streptococcal infection has been made. An original system for obtaining DNA of streptococcal group A (gene of streptococcal mf mitogen) using polymerase chain reaction was developed. An enzyme immunoassay test system for the detection of antibodies to the group-specific GSA antigen was developed as well. The system for prevention of the streptococcal group has been developed and put into practice, and high therapeutic and prophylactic efficacy of the local-made “Tomicide” drug was demonstrated.

Conducted research contributed to formulation of a new generation of sanitary-epidemiological rules and guidelines regulating measures for the streptococcal infection surveillance and prevention in Russia.

Guidelines for epidemiology and vaccination against pneumococcal infection were published as well.

N.I. Briko is the author of the “Globalisation – infectious diseases” paradigm.

He also took part in devising a new strategy of healthcare-associated infections in Russia.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies